Pactiv Evergreen Inc. (PTVE)
17.92
0.02 (0.11%)
At close: Mar 19, 2025, 3:59 PM
17.92
0.00%
Pre-market: Mar 20, 2025, 07:13 AM EDT
Pactiv Evergreen Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segments Revenue | 1.34B | 1.34B | 1.26B | 1.35B | 1.39B | 1.43B | 1.43B | 1.47B | 1.58B | 1.61B | 1.47B | 1.51B | 1.37B | 1.33B | 1.14B | 1.17B |
| Reportable Segments Revenue Growth | -0.37% | +6.76% | -6.82% | -2.74% | -2.73% | -0.21% | -2.79% | -7.14% | -1.86% | +9.50% | -2.19% | +10.25% | +2.86% | +17.00% | -2.58% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|
| Non-Us Revenue | 2M | 535M | 447M | 354M |
| Non-Us Revenue Growth | -99.63% | +19.69% | +26.27% | n/a |
| Rest Of North America Revenue | 522M | 5.51B | 4.71B | 4.05B |
| Rest Of North America Revenue Growth | -90.52% | +16.92% | +16.41% | n/a |
| United States Revenue | 4.99B | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 115M | 122M | 133M | 111M | 137M | 136M | 130M | 148M | 145M | 148M | 142M | 121M | 104M | 115M | 126M | 112M | 116M | 178M | 185M | 264M | 257M | 275M | 265M | 233M | 232M | 248M | 248M | 250M | 267M | 254M | 251M | 363M | 285M | 263M | 259M | 285M | 259M | 238M | 243M |
| Selling, General, and Administrative Revenue Growth | -5.74% | -8.27% | +19.82% | -18.98% | +0.74% | +4.62% | -12.16% | +2.07% | -2.03% | +4.23% | +17.36% | +16.35% | -9.57% | -8.73% | +12.50% | -3.45% | -34.83% | -3.78% | -29.92% | +2.72% | -6.55% | +3.77% | +13.73% | +0.43% | -6.45% | n/a | -0.80% | -6.37% | +5.12% | +1.20% | -30.85% | +27.37% | +8.37% | +1.54% | -9.12% | +10.04% | +8.82% | -2.06% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | 45M | n/a | n/a | n/a | 33M | n/a | n/a | n/a | 22M | n/a | n/a | n/a | 20M | n/a | n/a | n/a | 22M | n/a | n/a | n/a | 19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |